MRC1 and colorectal carcinoma: However, unlike cisplatin and carboplatin, dMMR CRC cells in vitro were sensitive to oxaliplatin, and this was attributed to a unique, bulky 1,2-diaminocyclohexane ligand of oxaliplatin that prevents MMR complex binding, more effectively inhibits DNA synthesis, and ultimately results in apoptosis [92].